Competing interests
TLL, Janssen, Johnson & Johnson, Kaleido,, Johnson & Johnson, Merck, MSD
BRUCE
Sylvio Danese: speaker, consultant, and advisory board member for AbbVie, Allergan plc, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Hospira, Johnson & Johnson, Merck, MSD, Mundipharma, Pfizer, Sandoz, Takeda, TiGenix, UCB Pharma, and Vifor Pharma.Andrew Beaton, Beth Duncan, Anne-Kristina Mercier, Jessica Neisen, Henrik Seth, and Sofia Zetterstrand: employees of AstraZeneca.Bruce Sands: consultant or received speaker’s fees from AbbVie, Abivax, Adiso, Alimentiv, Amgen, Arena, Artizan, Artugen, AstraZeneca, Bacainn, Biora, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Myers Squibb, Calibr, Celltrion Healthcare, ClostraBio, Connect Biopharm, Cytoki Pharma, Eli Lilly and Company, Entera, Evommune, Ferring, Fresenius Kabi, Galapagos, Gilead, Genentech, GlaxoSmithKline, Gossamer Bio, HMP Acquisition, Imhotex, Immunic, InDex, Innovation, Inotrem, Ironwood, Janssen, Johnson & Johnson, Kaleido, Kalyope, Merck, MiroBio, Morphic Therapeutic, MRM Health, OSE Immunotherapeutics, Pfizer, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonist, Q32 Bio, RedHill Biopharma, Sun Pharma Global, Surrozen, Synlogic Operating Company, Takeda, Target RWE, Theravance Biopharma R&D, TLL Pharmaceutical, USWM Enterprises, Ventyx, and Viela Bio, and received stock options from Ventyx Biosciences.